With over 50 years in respiratory care, GSK is committed to helping patients breathe better by continuously redefining treatment for COPD and asthma. We are driven by our commitment to research and uniting innovative science and technology to help people with these respiratory conditions live more comfortably. Equally prioritizing people and our scientific innovation, we endeavor to meet the needs of our entire patient community, so that even more patients achieve the best possible outcomes. In turn, we discover and develop new medicines and technologies that transform respiratory disease symptom management and improve overall lung health.
So long as people experience asthma and COPD exacerbations and symptoms, there is more for us to do. At GSK, our goal is to help people with respiratory conditions to not only live, but to live well.
COPD
Our commitment to people impacted by COPD
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the country, affecting approximately 27 million Americans. We aspire to continue researching and developing treatments that may shift the way people with COPD are treated.
Encouraging people with COPD to rethink their condition
Even with escalating symptoms, people with COPD are often reluctant to share important information about how it impacts them daily. That is why we aim to bridge communication gaps among people with COPD, healthcare providers and caregivers.
Visit COPD.com to learn more.
Asthma
Understanding asthma
While the exact cause of asthma is unknown, we know that not all asthma is the same. From uncontrolled asthma to severe eosinophilic asthma, we are committed to understanding the asthma community’s treatment needs.
Visit asthma.com to learn more about the different types of asthma and the role eosinophils may play in severe eosinophilic asthma.
Driving people with asthma to never settle
People living with asthma should not have to settle for persistent symptoms. It is critical that patients and their healthcare teams have open and honest communication that goes beyond the routine to truly understand the burden of symptoms on day-to-day life. This can help patients develop a better treatment plan and better manage the disease to live a more active life.
